Herantis Pharma Oyj (HRTIS) — Cash Flow Reinvestment Rate
Latest as of December 2013:
2299.45x
Herantis Pharma Oyj (HRTIS) has a Cash Flow Reinvestment Rate of 2299.45x as of December 2013, reinvesting €421.35K (capex €421.35K ) from operating cash flow of €183.24. See HRTIS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
2299.45x
(Capex + Investments) / Operating CF
Total Reinvested
€421.35K
Capex + Investments
Operating Cash Flow
€183.24
EUR
Capital Expenditures
€421.35K
EUR
Annual Cash Flow Reinvestment Rate for Herantis Pharma Oyj (None–None)
Year-by-year capital reinvestment analysis for Herantis Pharma Oyj. See HRTIS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow